Navigation Links
Luminex Corporation to Feature ARIES System and NxTAG Respiratory Pathogen Panel at AMP Annual Meeting
Date:10/28/2015

AUSTIN, Texas, Oct. 28, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it will be featuring the newly FDA-cleared ARIES® System and recently CE-marked NxTAG® Respiratory Pathogen Panel at the Association for Molecular Pathology (AMP) Annual Meeting occurring November 5 to 7, 2015 in Austin, Texas.   

About ARIES®
ARIES® is a sample to answer system crafted to increase laboratory efficiency, produce accurate results, and fit seamlessly into today's lean laboratory environment. The ARIES® System uses internal barcode scanning and other advanced features to minimize operator errors. Two independent modules each support from one to six cassettes, allowing for both STAT and Batch testing. IVD and MultiCode® Analyte Specific Reagents can be run simultaneously when using a common Universal Assay Protocol. An integrated touchscreen PC eliminates the need for a separate computer, stand-alone keyboard, and mouse; thus maximizing valuable bench space.

ARIES at AMP

  • Workshop: "Welcome to the New Way to Work: ARIES®, the Next Generation of Sample to Answer Testing," on Wednesday, November 4, 2015 at 9 am in Room 12B, Level 4. Stephen Young, PhD, D(ABMM), Scientific Director–Infectious Disease, TriCore Reference Laboratories, will present performance characteristics of ARIES® HSV 1&2 Assay based on the clinical trial data generated at TriCore and share the ARIES work experience at his laboratory.
  • Poster: "Improved Laboratory Workflow with ARIES®—A Time and Motion Study" (S. Dunbar/Luminex).
  • ARIES® Introduction: Thursday, November 5 at 3 pm at Booth #911: Luminex will officially mark the launch of ARIES® with remarks by customers in the early access program.

About NxTAG
NxTAG Respiratory Pathogen Panel is CE-marked in Europe, and available for Research Use Only (RUO) in the U.S. NxTAG Respiratory Pathogen Panel is an assay that detects relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila. The panel is the only respiratory assay that enables laboratories to easily and simultaneously detect these respiratory pathogens in a single, closed tube system and in a format that scales to accommodate changes in throughput needed to respond to seasonal changes in demand, especially during flu season. NxTAG Respiratory Pathogen Panel requires only minutes of hands-on time with no upstream reagent preparation. The innovative tube strip design offers laboratories the flexibility to process a single sample or up to 96 samples per run, without wasting consumables or reagents. Total turnaround time is only about three hours for 96 samples (excluding extraction).

NxTAG at AMP

  • Workshop:"NxTAG Respiratory Pathogen Panel (RUO)*—The New Paradigm in Molecular Respiratory Disease Testing," Wednesday, November 4, 2015 at 3 pm in Room 12B, Level 4. Dr. Catherine Moore from Public Health Wales will describe a prospective study to determine baseline respiratory pathogen levels in sudden death cases. In combination with culture and histology, the NxTAG Respiratory Pathogen Panel (RUO) revealed that respiratory viruses are frequently detected in the respiratory tracts of these individuals, and especially in infants. Dr. Arundhati Rao from Scott & White Memorial Hospital will present results of the NxTAG clinical study conducted at her laboratory and share some insights from a time and motion study comparing NxTAG to other molecular respiratory disease assays.
  • Posters: "Automation of the Luminex NxTAG Respiratory Pathogen Panel (RUO)" (M. Phillips/Luminex); "Assessment of a High Throughput Next Generation Multiplex Respiratory Pathogen Panel" (J.H. Chen/Queen Mary Hospital, Hong Kong; LMD); "Workflow Evaluation of the Luminex NxTAG Respiratory Pathogen Panel (RUO)" (K. Post/IU Health).

AMP Events Sponsored by Luminex

  • International Showcase Event, Wednesday, November 4, 2015 at 7 pm. This event will feature selected case study presentations on international collaborations with members outside the U.S. and updates on the initiatives of the International Affairs Committee and AMP's international affiliates. 
  • Science Educator Workshop, Wednesday, November 4, 2015 from 7:30 am–3:35 pm. AMP will be hosting a complimentary workshop for Austin area educators at local high schools and colleges. The goal is to introduce molecular diagnostics as a valuable and in-demand field of study to these science teachers.

About Luminex Corporation
Luminex is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life science companies. Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research, and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.

Contacts:
Luminex Media Contact
Christine Valle, 512.219.8020
Sr. Manager, Global Marketing
cvalle@luminexcorp.com

Additional Media Contact
Nicole Litchfield, 415.793.6468
/nicole@bioscribe.com" rel="nofollow" target="_blank">nicole@bioscribe.com

Investor Contact
Harriss Currie, 512.219.8020
Sr. Vice President of Finance and CFO
hcurrie@luminexcorp.com

*For Research Use Only. Not for use in diagnostic procedures.

 

Photo - http://photos.prnewswire.com/prnh/20151028/281558
Photo - http://photos.prnewswire.com/prnh/20151028/281559 
Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO


'/>"/>
SOURCE Luminex Corporation
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership
2. Luminex Corporation Third Quarter Earnings Release Scheduled for November 2, 2015
3. Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference
4. Luminex Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference
5. Luminex Corporation Reports Record 2nd Quarter 2015 Results
6. Luminex Corporation Second Quarter Earnings Release Scheduled for August 3, 2015
7. Luminex Corporation Reports First Quarter 2015 Results
8. Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R)
9. Luminex Corporation First Quarter Earnings Release Scheduled for May 4, 2015
10. Luminex Technology Selected by Assurex Health
11. Luminex Corporation To Present At Cowen And Company 35th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Center and Grayken Center for Addiction will help combat the opioid epidemic by ... combines two pharmacy-specific educational interventions that have shown promise in reducing opioid-related harms, ...
(Date:6/11/2019)... ... June 11, 2019 , ... Intalere, ... today announced the latest enhanced release of OptiAnalytics Navigate. This best-in-class strategic ... customers. , “We are thrilled to offer these customer-focused new features ...
(Date:6/11/2019)... ... June 11, 2019 , ... MabPlex ... Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China ... the company's new Chief Executive Officer (CEO). Dr Chen will be responsible for ...
Breaking Medicine Technology:
(Date:6/13/2019)... ... June 13, 2019 , ... ... SGLT-2 Inhibitors” presented at the American Diabetes Association (ADA) Scientific Sessions 2019 involving ... being treated with an SGLT-2 inhibitor. SGLT-2 inhibitors are used to lower glucose ...
(Date:6/12/2019)... ROCHELLE, Va. (PRWEB) , ... June 12, 2019 ... ... that Andrea Miller, a quality assurance expert with more than 25 years of ... and MDD Compliance for all classes of medical devices, has joined NDA Partners ...
(Date:6/12/2019)... ... June 12, 2019 , ... Ovation Travel Group, ... today announced that its Chairman and CEO Paul Metselaar has received the Children’s ... last Wednesday evening at New York City’s Capitale as part of the Children’s ...
(Date:6/12/2019)... ... June 12, 2019 , ... Millions of people across ... from participating in education or the workforce, and even from accessing health care. ... as a human right and address communication disability in ways that foster inclusion ...
(Date:6/11/2019)... ... 11, 2019 , ... The FSH Society today announced that ... regulators, biopharma companies, and academic thought leaders to discuss the current state of ... the world’s largest research-focused patient advocacy organization for FSHD, a hereditary muscle-damaging condition ...
Breaking Medicine News(10 mins):